MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 13.02.2026
Edesa Biotech Kurshistorie 2011-2026 | EDSA
Kurshistorie Jährlich Edesa Biotech
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | 5.01 | 0.94 | 3.71 | 5.52 | 2.63 | 7.02 | 33.2 | 64.3 | 281 | 403 | 622 | 260 | 210 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 622 | 0.94 | 136 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | France |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
BioNTech SE
BNTX
|
91.2 | $ 94.95 | -0.58 % | $ 27.2 B | Germany |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | USA |
 |
INmune Bio
INMB
|
1.14 | $ 1.53 | -0.65 % | $ 37.9 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 22.06 | -1.3 % | $ 3.66 B | USA |
 |
Exelixis
EXEL
|
43.1 | $ 48.46 | 9.1 % | $ 13.2 B | USA |
 |
Fortress Biotech
FBIO
|
2.79 | $ 2.56 | 3.86 % | $ 71.4 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
2.7 | $ 3.14 | 0.87 % | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.46 | -1.14 % | $ 5.7 M |  Israel |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 24.04 | 2.65 % | $ 3.06 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 55.27 | 5.52 % | $ 4.97 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.72 | 4.57 % | $ 458 M | Britain |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | Britain |
 |
Galapagos NV
GLPG
|
28.9 | $ 28.81 | 1.48 % | $ 2.69 B |  Belgium |
 |
Genmab A/S
GMAB
|
33.5 | $ 27.95 | 1.48 % | $ 17.2 B |  Danmark |